BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2014 5:12:00 PM | Browse: 739 | Download: 729
Publication Name World Journal of Gastroenterology
Manuscript ID 7460
Country Brazil
Received
2013-11-20 14:16
Peer-Review Started
2013-11-20 16:19
To Make the First Decision
Return for Revision
Revised
2014-02-11 09:28
Second Decision
2014-04-09 09:23
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-09 11:01
Articles in Press
2014-05-23 11:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-04-14 21:39
Typeset the Manuscript
2014-07-03 17:03
Publish the Manuscript Online
2014-07-21 17:17
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Treatment of Crohn’s disease in pregnant women: Drug and multidisciplinary approaches
Manuscript Source Invited Manuscript
All Author List Didia Bismara Cury and Alan C Moss
Funding Agency and Grant Number
Corresponding Author Didia Bismara Cury, Director, Center of Inflammatory Bowel Disease, Clinica Scope, Campo Grande, MS 79002212, Brazil. didia_cury@uol.com.br
Key Words Pregnancy; Drugs; Inflammatory bowel disease; Crohn’s disease; Breastfeeding
Core Tip Patients should be encouraged to postpone conception until their Crohn’s disease (CD) is in remission. Monitoring of nutritional status remains important in patients with small bowel CD; folic acid, vitamin D and vitamin B12 may all need to be supplemented. Most drug treatments are safe in pregnancy, based on observational data, including 5-aminosalicylic acid, thiopurines, anti-tumor necrosis factor, and anti-integrins. Methotrexate should be avoided due to its teratogenicity. Cesarean section is only indicated from a CD perspective in women with active perianal disease at the time of delivery; all others can have a normal vaginal delivery.
Publish Date 2014-07-21 17:17
Citation Cury DB, Moss AC. Treatment of Crohn’s disease in pregnant women: Drug and multidisciplinary approaches. World J Gastroenterol 2014; 20(27): 8790-8795
URL http://www.wjgnet.com/1007-9327/full/v20/i27/8790.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i27.8790
Full Article (PDF) WJG-20-8790.pdf
Full Article (Word) WJG-20-8790.doc
Manuscript File 7460-Review.docx
Answering Reviewers 7460-Answering reviewers.pdf
Copyright License Agreement 7460-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 7460-Language certificate.pdf
Peer-review Report 7460-Peer review(s).pdf
Scientific Editor Work List 7460-Scientific editor work list.doc